Abstract:
Disclosed are polypeptides of general structural formula (I) X n -C 1 -X 1-50 -C 2 -X 0-5 -C 3 -X 1-100 -C 4 -X 1-100 -C 5 -X 1-50 -C 6 -X 0-5 -C 7 -X 1-50 -C 8 -X m as well as the production and use thereof.
Abstract translation:结构通式(I)中X 名词 SUB> -C 1 SUP> X 1-50 SUB> -C 2 SUP> -X多肽 0-5 SUB> -C 3 SUP> X 1-100 SUB> -C 4 SUP> X 1-100 SUB> -C 5 SUP> X 1-50 SUB> -C 6 SUP> X 0-5 SUB> -C 7 SUP> X 1-50 SUB> -C 8 SUP> X 米 SUB>,它们的制备和用途。
Abstract:
The invention relates to a cosmetic composition for treating materials containing keratin, mucous membranes and teeth, said composition containing at least one hydrophobin polypeptide sequence (i) X n -C 1 -X 1-50 -C 2 -X 0-5 -C 3 -X p -C 4 -X 1-100 -C 5 -X 1-50 -C 6 -X 0-5 -C 7 -X 1-50 -C 8 -X m (I).
Abstract translation:用于处理角蛋白材料,粘膜和牙齿的化妆品组合物,其包含至少一种疏水蛋白多肽序列(I)中X 名词 SUB> -C 1 SUP> X 1-50 SUB > -C 2 SUP> X 0-5 SUB> -C 3 SUP> X p SUB> -C 4 < / SUP> X 1-100 SUB> -C 5 SUP> X 1-50 SUB> -C 6 SUP> -X < SUB> 0-5 SUB> -C 7 SUP> X 1-50 SUB> -C 8 SUP> X 米 SUB >(I)
Abstract:
The invention relates to polypeptides of general structural formula (I) X n -C 1 -X 1-50 -C 2 -X 0-5 -C 3 -X P -C 4 -X 1-100 -C 5 -X 1-50 -C 6 -X 0-5 -C 7 -X 1-50 -C 8 -X m , to their production and use thereof.
Abstract translation:结构通式(I)中X 名词 SUB> -C 1 SUP> X 1-50 SUB> -C 2 SUP> -X多肽 0-5 SUB> -C 3 SUP> X P SUB> -C 4 SUP> X 1-100 SUB> -C 5 SUP> X 1-50 SUB> -C 6 SUP> X 0-5 SUB> -C 7 SUP> X 1-50 SUB> -C 8 SUP> XM(I),它们的制备和用途。
Abstract:
Disclosed are a method for coating surfaces with fusion hydrophobins at a pH value of > 4 as well as a surface comprising a coating which contains at least one fusion hydrophobin.
Abstract:
Method for determining the regulatory properties of a genetic element, which comprises the following steps: a) introducing a DNA molecule having a DNA-I sequence whose regulatory properties are to be determined into a cell, said DNA-I sequence being linked with an additional DNA-II sequence encoding a laccase from Aspergillus nidulans in such a manner that the regulatory elements of the DNA-I sequence control expression of the laccase, b) cultivating the cells obtained in step (a) under conditions allowing expression of the laccase, c) associating the conditions selected under (b) with the regulatory properties of the DNA-I sequence.
Abstract:
The invention relates to novel keratin-binding protein materials and to their production and use. Particularly suitable keratin-binding polypeptides are those sequences that are contained in the human protein desmoplakin or that can be derived from modifications of human desmoplakin polypeptide sequences, such as amino acid insertions, substitutions or deletions. The polypeptide sequence of human desmoplakin is represented in SEQ ID NO: 1. A suitable keratin-binding domain (domain B) is the polypeptide sequence SEQ ID No: 1, position 2193 to 2481 and its functional equivalents. An additional keratin-binding domain (domain C) is the polypeptide sequence SEQ ID NO: 1, position 2606 to 2871 and its functional equivalents.
Abstract translation:本发明涉及新的角蛋白的结合蛋白的药物,其制备和用途。 特别合适的蝼锡结合多肽是包含在人类桥粒斑或通过修改人类Desmoplakinpolypeptidsequenzen如氨基酸插入,取代或它们的衍生缺失的那些序列。 人类桥粒斑蛋白的多肽序列为SEQ ID KO:1。 合适的角蛋白的结合结构域(结构域B)是该多肽序列SEQ ID WO:1点的位置2193至2481年,以及它们的功能等同物。 进一步的角蛋白的结合结构域(结构域C)是该多肽序列SEQ ID NO:1点的位置2606年至2871年,以及它们的功能等同物。
Abstract:
The invention relates to a method for coating fibre substrates selected form textile or leather substrates with the aid of at least one type of hydrophobin.
Abstract:
The invention relates to a cosmetic composition for treating materials containing keratin, mucous membranes and teeth, said composition containing at least one hydrophobin polypeptide sequence (i) Xn-C1-X1-50-C2-X0-5-C3-Xp-C4-X1-100-C5-X1-50-C6-X0-5-C7-X1-50-C8-Xm (I).
Abstract:
The invention relates to the use of at least one protein, especially at least one hydrophobin or at least one derivative thereof, for improving the phase separation in compositions containing at least two liquid phases. The invention also relates to a method for separating at least two liquid phases in a composition containing at least two liquid phases, and formulations containing at least one compound selected from the group consisting of fuels, combustibles, crude oil or water-soluble or oil-soluble polymer solutions, and at least one protein, especially at least one hydrophobin or derivatives thereof.